We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Sabrina
Kapur
Sabrina.kapur@imperial.ac.uk
Reiko
Tanaka
r.tanaka@imperial.ac.uk
Dermatitis and eczema
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
Background:
Eczema is an itchy skin condition that affects 20% of UK children. Constant itching and sleep loss result in poor quality of life that affects the whole family.
Following the pandemic, many more consultations for eczema are taking place by video calls and by sending in photographs. However, assessing eczema severity on photographs is challenging. Doctors and nurses need better support for telephone/video assessment of eczema severity to provide the best treatment advice for people with eczema.
We have developed a computer software (called EczemaNet) that helps doctors and nurses to assess eczema severity from photographs. The software, also known as a machine learning algorithm, works well on white skin but is less accurate for assessing darker skin tones as the software was mainly developed using images of eczema on white skin.
Aim:
We will train the computer software so that it can score eczema severity in children and young people of ALL skin types.
Methods:
We will collect over 5,000 digital images of eczema in children and young people with a range of darker skin tones, pair these images with face-to-face assessments of eczema severity by clinical staff, and then expand the image bank by making over 200,000 computer-generated images.
These images are then used to 'train' the computer software to estimate eczema severity reliably on digital images. The computer software will learn to score the seven visible aspects of eczema that doctors look for when assessing eczema (dryness, cracking, redness/colour change, scratch marks, oozing, thickening, and swelling).
We will also get feedback on user-friendliness from children/carers and doctors.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
Observational type: Validation of investigation /therapeutic procedures;
You can take part if:
You may not be able to take part if:
- Eczema diagnosis not confirmed. - Severe underlying medical conditions that may present with eczematous lesions (not common in allergy clinics).
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
The study is sponsored by Imperial College of Science, Technology and Medicine and funded by NIHR Central Commissioning Facility (CCF) .
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Read full details
for Trial ID: CPMS 56817
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
